At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to ...
Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...
Coartem Baby was developed by Novartis with the scientific and financial support of MMV, and as part of the PAMAfrica ...
Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs. Novartis works with healthcare professionals (HCPs) to ...
ノバルティス ファーマは、日本血液学会、福島県医師会、三重県医師会と共同事業契約を締結し、“地域医療体制の再定義による偏在解消プロジェクト”として「HEMA-Bridge事業」を開始 全国 ...
No Offer or Solicitation This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or ...
Scales program footprint from 11 countries to more than 30 by 2030, including across five cities in the U.S. Builds on pilot programs that demonstrated significant increase in control rates for high ...
Der Novartis Campus Basel ist der globale Hauptsitz von Novartis. Etwa 7 000 Mitarbeitende sind in diesem modernen Zentrum für Forschung, Entwicklung und Management tätig, in dem divisions- und ...
Genske terapije spremenijo del pacientove genetske zgradbe v pomoč pri zdravljenju genetskih ali dednih bolezni. Celične terapije zdravijo bolezni z obnavljanjem ali spreminjanjem določenih skupin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results